With a more convenient oral formulation, Novo can position itself as a competitor to traditional diabetes medications, such as metformin, sulfonylureas, and SGLT2 inhibitors that are taken by mouth
About side effects and management: "What are the most common side effects during the first few weeks?" "How should I adjust my diet to minimize gastrointestinal side effects ?" "When should I call your office about side effects versus managing them at home?" "Are there any supplements I should take alongside this medication ?" "Could this medication interact with anything I currently take ?" Side effect questions show maturity and realism
GLP-1 Receptor Agonists [review]
This means widespread access might not come until 2027-2028 or later
Supply Shortages: Due to increased demand, theres been a shortage of semaglutide injection products (Ozempic and Wegovy) since 2022
CMs) may be required to parse the cell-specific role of this cAMP-generating pathway in IRI, with the lack of GLP-1(2836) responses in sAC / caSMCs providing a strong rationale